SPARC and metastatic prostate carcinoma: We found that plasma SPARC levels in metastatic prostate cancer patients tended to be lower than those in non-metastatic cases or control individuals (Figure 6d), and thus we conclude that plasma levels of SPARC in prostate cancer patients do not reflect tumoral SPARC expression levels.